ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Estimating the Lifetime Costs in Adult Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in the United States
Value in Health
◽
10.1016/j.jval.2018.04.172
◽
2018
◽
Vol 21
◽
pp. S27
Author(s):
J Garcia
◽
S Snyder
◽
M Gitlin
Keyword(s):
United States
◽
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
The United States
◽
Adult Patients
◽
Large B Cell Lymphoma
◽
Lifetime Costs
◽
Large B Cell
Download Full-text
Related Documents
Cited By
References
Cost effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for adult patients with relapsed or refractory large B-cell lymphoma after 2 or more lines of systemic therapy in the United States
Journal of Medical Economics
◽
10.1080/13696998.2021.1901721
◽
2021
◽
pp. 1-1
Author(s):
Rongzhe Liu
◽
Olalekan O Oluwole
◽
Ibrahim Diakite
◽
Marc F Botteman
◽
Julia Thornton Snider
◽
...
Keyword(s):
United States
◽
Cost Effectiveness
◽
B Cell
◽
Systemic Therapy
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
The United States
◽
Adult Patients
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Cost-effectiveness of axicabtagene ciloleucel for adult patients with relapsed or refractory large B-cell lymphoma in the United States
Journal of Medical Economics
◽
10.1080/13696998.2018.1529674
◽
2018
◽
Vol 21
(12)
◽
pp. 1238-1245
◽
Cited By ~ 18
Author(s):
Joshua A. Roth
◽
Sean D. Sullivan
◽
Vincent W. Lin
◽
Aasthaa Bansal
◽
Anna G. Purdum
◽
...
Keyword(s):
United States
◽
Cost Effectiveness
◽
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
The United States
◽
Adult Patients
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
PF321 REAL-WORLD TREATMENT PATTERNS OF PATIENTS DIAGNOSED WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) IN THE UNITED STATES (US)
HemaSphere
◽
10.1097/01.hs9.0000559496.29967.d6
◽
2019
◽
Vol 3
(S1)
◽
pp. 113
Author(s):
X. Yang
◽
F. Laliberté
◽
G. Germain
◽
M. Raut
◽
M.S. Duh
◽
...
Keyword(s):
United States
◽
B Cell
◽
Real World
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
The United States
◽
Treatment Patterns
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States
American Journal of Hematology
◽
10.1002/ajh.23726
◽
2014
◽
Vol 89
(7)
◽
pp. 714-720
◽
Cited By ~ 26
Author(s):
Todd M. Gibson
◽
Eric A. Engels
◽
Christina A. Clarke
◽
Charles F. Lynch
◽
Dennis D. Weisenburger
◽
...
Keyword(s):
United States
◽
B Cell
◽
Organ Transplantation
◽
Cell Lymphoma
◽
Solid Organ Transplantation
◽
B Cell Lymphoma
◽
The United States
◽
Solid Organ
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Disparities in the Early Adoption of Chemoimmunotherapy for Diffuse Large B-cell Lymphoma in the United States
Cancer Epidemiology Biomarkers & Prevention
◽
10.1158/1055-9965.epi-12-0466
◽
2012
◽
Vol 21
(9)
◽
pp. 1520-1530
◽
Cited By ~ 49
Author(s):
Christopher R. Flowers
◽
Stacey A. Fedewa
◽
Amy Y. Chen
◽
Loretta J. Nastoupil
◽
Joseph Lipscomb
◽
...
Keyword(s):
United States
◽
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
The United States
◽
Large B Cell Lymphoma
◽
Early Adoption
◽
Large B Cell
Download Full-text
Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma
Cancer
◽
10.1002/cncr.20956
◽
2005
◽
Vol 103
(8)
◽
pp. 1644-1651
◽
Cited By ~ 37
Author(s):
John C. Hornberger
◽
Jennie H. Best
Keyword(s):
United States
◽
Elderly Patients
◽
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
The United States
◽
Cost Utility
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
EPR21-034: Epidemiology of Diffuse Large B Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL) Patients by Line of Therapy in the United States (US) and Europe (EU)
Journal of the National Comprehensive Cancer Network
◽
10.6004/jnccn.2020.7742
◽
2021
◽
Vol 19
(3.5)
◽
pp. EPR21-034
Author(s):
Wenzhen Ge
◽
Jon E. Arnason
◽
Ruben G.W. Quek
◽
Katie Keeven
◽
Knar Nersesyan
◽
...
Keyword(s):
United States
◽
Follicular Lymphoma
◽
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
The United States
◽
Large B Cell Lymphoma
◽
Line Of Therapy
◽
Large B Cell
Download Full-text
PCN238 IS POLATUZUMAB VEDOTIN PLUS BENDAMUSTINE-RITUXIMAB COST-EFFECTIVE FOR PATIENTS IN THE UNITED STATES WITH TRANSPLANT-INELIGIBLE RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA?
Value in Health
◽
10.1016/j.jval.2019.09.433
◽
2019
◽
Vol 22
◽
pp. S482
Author(s):
K.A. Betts
◽
P.O. Thuresson
◽
E.X. Du
◽
I. Dieye
◽
J. Li
◽
...
Keyword(s):
United States
◽
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
Cost Effective
◽
The United States
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Intravascular large B-cell lymphoma in the United States (US): a population-based study using Surveillance, Epidemiology, and End Results program and National Cancer Database*
Leukemia & Lymphoma
◽
10.1080/10428194.2017.1287363
◽
2017
◽
Vol 58
(9)
◽
pp. 2080-2088
◽
Cited By ~ 17
Author(s):
Devalkumar J. Rajyaguru
◽
Chaithanya Bhaskar
◽
Andrew J. Borgert
◽
Angela Smith
◽
Benjamin Parsons
Keyword(s):
United States
◽
B Cell
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
The United States
◽
Population Based
◽
National Cancer Database
◽
Population Based Study
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Unstaged Diffuse Large B-Cell Lymphoma in the United States: Predictors and Patient Outcomes
Anticancer Research
◽
10.21873/anticanres.11533
◽
2017
◽
Vol 37
(4)
◽
pp. 1935-1939
Keyword(s):
United States
◽
B Cell
◽
Patient Outcomes
◽
Cell Lymphoma
◽
B Cell Lymphoma
◽
The United States
◽
Large B Cell Lymphoma
◽
Large B Cell
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close